用Cemiplimab有效管理鼻腔前庭状细胞癌:一个病例报告
Ferdinando Costabile1,2, Marianna Donnarumma3, Arianna Piscosquito1
1Oncolgy Unit, "Andrea Tortora" Hospital, ASL Salerno, Pagani, Italy.
Case reports in oncology
|October 30, 2023
概括
鼻腔前庭状细胞癌 (SCC) 的治疗选择有限. 一名患有这种罕见癌症的83岁患者对塞米普利马布 (抗PD-1抗体) 治疗反应良好,显示显著的瘤减少,没有副作用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 鼻前庭状细胞癌 (SCC) 是一种罕见的恶性瘤.
- 对于晚期或无法切除的病例,有效的治疗选择有限.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.2K
